Y
Yoichi M. Ito
Researcher at Hokkaido University
Publications - 287
Citations - 9419
Yoichi M. Ito is an academic researcher from Hokkaido University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 32, co-authored 242 publications receiving 8274 citations. Previous affiliations of Yoichi M. Ito include RMIT University & Kawasaki Steel Corporation.
Papers
More filters
Journal ArticleDOI
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase
Toshimasa Yamauchi,Junji Kamon,Yasuhiko Minokoshi,Yoichi M. Ito,Hironori Waki,S. Uchida,Shigeo Yamashita,Mitsuhiko Noda,Shunbun Kita,K Ueki,Koji Eto,Y. Akanuma,Philippe Froguel,Fabienne Foufelle,Pascal Ferré,David Carling,Shigeko Kimura,Ryozo Nagai,Barbara B. Kahn,Takashi Kadowaki +19 more
TL;DR: It is shown that phosphorylation and activation of the 5′-AMP-activated protein kinase (AMPK) are stimulated with globular and full-length Ad in skeletal muscle and only with full- lengths Ad in the liver, indicating that stimulation of glucose utilization and fatty-acid oxidation by Ad occurs through activation of AMPK.
Journal ArticleDOI
Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease
Masaharu Nishimura,Hironi Makita,Katsura Nagai,Satoshi Konno,Yasuyuki Nasuhara,Masaru Hasegawa,Kaoruko Shimizu,Tomoko Betsuyaku,Yoichi M. Ito,Satoshi Fuke,Takeshi Igarashi,Yasushi Akiyama,Shigeaki Ogura +12 more
TL;DR: Emmphysema severity is independently associated with a rapid annual decline in FEV1 in COPD, and the Sustainers and Rapid decliners warrant specific attention in clinical practice.
Journal ArticleDOI
Antiviral Therapy for Cirrhotic Hepatitis C: Association with Reduced Hepatocellular Carcinoma Development and Improved Survival
Yasushi Shiratori,Yoichi M. Ito,Osamu Yokosuka,Fumio Imazeki,Ryo Nakata,Naohide Tanaka,Yasuyuki Arakawa,Etsuko Hashimoto,Katsutaro Hirota,Haruhiko Yoshida,Yasuo Ohashi,Masao Omata +11 more
TL;DR: A 7-year study on the inhibition of hepatocellular carcinoma development in the previous cohorts of the multicenter, prospective study of adults with chronic hepatitis C and cirrhosis to determine whether interferon therapy benefits cirrhotic patients.
Journal ArticleDOI
Interleukin-1β gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection
Yue Wang,Naoya Kato,Yujin Hoshida,Hideo Yoshida,Hiroyoshi Taniguchi,Tadashi Goto,Masaru Moriyama,Motoyuki Otsuka,Shuichiro Shiina,Yasushi Shiratori,Yoichi M. Ito,Masao Omata +11 more
TL;DR: The IL‐1β‐31 genotype T/T or the IL‐ 1β‐511/‐31 haplotype C‐T is associated with the presence of HCC in Japanese patients with chronic HCV infection.
Journal ArticleDOI
Sensitivity and Specificity of Des-Gamma-Carboxy Prothrombin for Diagnosis of Patients with Hepatocellular Carcinomas Varies According to Tumor Size
Shinichiro Nakamura,Kazuhiro Nouso,Kohsaku Sakaguchi,Yoichi M. Ito,Yasuo Ohashi,Yoshiyuki Kobayashi,Nobuyuki Toshikuni,Hironori Tanaka,Yasuhiro Miyake,Eiji Matsumoto,Yasushi Shiratori +10 more
TL;DR: The utility of DCP for the diagnosis of HCC was lower than that of AFP for small tumors, but higher than that in tumors greater than 5 cm in diameter, compared with AFP for large tumors.